These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 25747661)
1. The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver. Arshad MI; Piquet-Pellorce C; Filliol A; L'Helgoualc'h A; Lucas-Clerc C; Jouan-Lanhouet S; Dimanche-Boitrel MT; Samson M J Mol Med (Berl); 2015 Aug; 93(8):867-78. PubMed ID: 25747661 [TBL] [Abstract][Full Text] [Related]
2. The role of PARP activation in glutamate-induced necroptosis in HT-22 cells. Xu X; Chua CC; Zhang M; Geng D; Liu CF; Hamdy RC; Chua BH Brain Res; 2010 Jul; 1343():206-12. PubMed ID: 20451505 [TBL] [Abstract][Full Text] [Related]
3. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury. Tao X; Chen X; Hou Z; Hao S; Liu B World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177 [TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice. Huang S; Zhang B; Chen Y; Liu H; Liu Y; Li X; Bao Z; Song Z; Wang Z J Pharmacol Exp Ther; 2018 Mar; 364(3):452-461. PubMed ID: 29317476 [TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) Polymerase (PARP) is Critically Involved in Liver Ischemia/Reperfusion-injury. Haga S; Kanno A; Morita N; Jin S; Matoba K; Ozawa T; Ozaki M J Surg Res; 2022 Feb; 270():124-138. PubMed ID: 34656890 [TBL] [Abstract][Full Text] [Related]
7. Targeting intestinal epithelial cell-programmed necrosis alleviates tissue injury after intestinal ischemia/reperfusion in rats. Li X; Ling Y; Cao Z; Shen J; Chen S; Liu W; Yuan B; Wen S J Surg Res; 2018 May; 225():108-117. PubMed ID: 29605020 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis. Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of tumor necrosis factor-α converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis. Sharma M; Mohapatra J; Malik U; Wagh A; Singh A; Patel HM; Pandey D; Kadam S; Shah GB; Chatterjee A; Jain MR Int Immunopharmacol; 2013 Oct; 17(2):229-36. PubMed ID: 23816535 [TBL] [Abstract][Full Text] [Related]
10. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice. Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593 [TBL] [Abstract][Full Text] [Related]
12. Necrostatin-1 accelerates time to death in a rat model of cecal ligation and puncture and massively increases hepatocyte caspase-3 cleavage. Zhang Q; Wei S; Lu J; Fu W; Chen H; Huang Q; Chen Z; Zeng Z Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G551-G561. PubMed ID: 30735454 [TBL] [Abstract][Full Text] [Related]
14. [Protective effect of necrostatin-1 on the liver of rats with trauma induced hemorrhagic shock]. Zhang L; Cui Y; Wang B; Yu J; Wang Y; Wang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jan; 26(1):17-22. PubMed ID: 24649521 [TBL] [Abstract][Full Text] [Related]
15. PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells. Huang SH; Xiong M; Chen XP; Xiao ZY; Zhao YF; Huang ZY Oncol Rep; 2008 Sep; 20(3):567-72. PubMed ID: 18695907 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Poly(ADP-Ribose) Polymerase Increased Lipid Accumulation Through SREBP1 Modulation. Pang J; Cui J; Xi C; Shen T; Gong H; Dou L; Lin Y; Zhang T Cell Physiol Biochem; 2018; 49(2):645-652. PubMed ID: 30165350 [TBL] [Abstract][Full Text] [Related]
17. RIP1-Dependent Programmed Necrosis is Negatively Regulated by Caspases During Hepatic Ischemia-Reperfusion. Rosentreter D; Funken D; Reifart J; Mende K; Rentsch M; Khandoga A Shock; 2015 Jul; 44(1):72-6. PubMed ID: 26009812 [TBL] [Abstract][Full Text] [Related]
18. PARP2 deficiency affects invariant-NKT-cell maturation and protects mice from concanavalin A-induced liver injury. Filliol A; Piquet-Pellorce C; Dion S; Genet V; Lucas-Clerc C; Dantzer F; Samson M Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G399-G409. PubMed ID: 28751426 [TBL] [Abstract][Full Text] [Related]
19. Roles of inhibitors of poly(ADP-ribose) polymerase in protecting rat RINm5F cell line against free fatty acid-induced apoptosis. Mao X; Wang S; Pan Y; He B; Chen J; Jiang H; Zeng Q; Xu X Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):274-82. PubMed ID: 19513971 [TBL] [Abstract][Full Text] [Related]
20. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]